Pura Vida Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Pura Vida Investments’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-83,154	Closed	-$417K	–	184
2022 Q4	$417K	Sell	83,154 -52,542	-39%	-$329K	0.02%	170
2022 Q3	$1.77M	Buy	+135,696	New	+$2.06M	0.1%	141
2022 Q1	–	Sell	-42,069	Closed	-$745K	–	296
2021 Q4	$745K	Sell	42,069 -1,248	-3%	-$23.9K	0.03%	195
2021 Q3	$911K	Buy	+43,317	New	+$954K	0.03%	228

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Pura Vida Investments's NGM Position: Q1 2023 in Review

Pura Vida Investments sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2023, closing a stake of 83,154 shares — an estimated $417K sold.

Pura Vida Investments first reported a position in NGM in Q3 2021 and held it in 4 quarters. The position peaked at $1.77M in Q3 2022. 122 funds tracked by Wall St. Rank hold NGM as of Q1 2023.

Pura Vida Investments reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 83,154 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $417K.
Pura Vida Investments first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Pura Vida Investments's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.77M in Q3 2022.
122 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.